13F Portfolios

Avidity Partners Management LP: ORUKA THERAPEUTICS INC (ORKA): Quarterly 13F Position History

As of Q2 2026, Avidity Partners Management LP reported 760,424 shares of ORUKA THERAPEUTICS INC (ORKA), worth $72.4M and representing 11.6% of its 13F equity book. The position first appeared in Q3 2024 and has been disclosed across 8 13F-HR filings in Pactolio's tracked window.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 8 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q2 2026 760,424 0 $72.4M 11.6% $95.2
Q1 2026 760,424 +100,000 +15.1% $52.0M 11.8% $68.4
Q4 2025 660,424 0 $20.0M 5.8% $30.3
Q3 2025 660,424 +308,300 +87.6% $12.7M 2.9% $19.2
Q2 2025 352,124 0 $3.9M 0.8% $11.2
Q1 2025 352,124 0 $3.6M 0.7% $10.3
Q4 2024 352,124 438,802 -55.5% $6.8M 0.7% $19.4
Q3 2024 790,926 $19.4M 1.0% $24.5

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.

When did Avidity Partners Management LP first disclose a ORKA position in 13F-HR filings?

Avidity Partners Management LP first reported ORUKA THERAPEUTICS INC (ORKA) on its 13F-HR filing for the period ending 2024-09-30 (Q3 2024). The position has appeared on 8 reported quarters within Pactolio's tracked window.

What was Avidity Partners Management LP's most recent quarter-over-quarter share-count change in ORKA?

Avidity Partners Management LP held the same 760,424 shares of ORKA between Q1 2026 and Q2 2026, so the reported share count was unchanged quarter-over-quarter.

Does the implied price-per-share represent Avidity Partners Management LP's cost basis in ORKA?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.